US 7622447
Use of glutathione synthesis stimulating compounds in reducing insulin resistance
granted A61KA61K31/00A61K31/198
Quick answer
US patent 7622447 (Use of glutathione synthesis stimulating compounds in reducing insulin resistance) held by DiaMedica Inc. expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DiaMedica Inc.
- Grant date
- Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/00, A61K31/198, A61K31/385, A61K31/425